【レポートの概要（一部）】
1. Report Overview
1.1 Pharma Contract Manufacturing: World Market Overview
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by This Analysis
1.5 Who is This Study For?
1.6 Research and Analysis Methods
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain
2. Pharma Contract Manufacturing
2.1 An Introduction to Pharma Contract Manufacturing
2.1.1 Why Outsource in the Pharma Industry?
2.1.2 Services Offered by CMOs
2.1.3 Tactical and Strategic Manufacturing Outsourcing
2.1.4 Trends in Contract Manufacturing 2015-2025
3. The Pharma Contract Manufacturing Market: Outlook and Forecast 2015-2025
3.1 The Pharma Contract Manufacturing: Market Performance 2012-2013
3.1.1 Contract Manufacturing Is the Most Mature Pharma Outsourcing Sector
3.1.2 The Pharma Contract Manufacturing Market by Sector 2013
3.2 Pharma Contract Manufacturing: Overall Market Forecast 2015-2025
3.2.1 What Will Drive Growth for Contract Manufacturers 2015-2025?
3.2.2 Will Generics Drive or Restrain Market Growth?
3.2.3 Outlook and Revenue Forecast for Other Contract Manufacturing Services 2015-2025
3.2.3.1 Rising Demand for Formulation Development Services
3.3 Clinical and Commercial Manufacturing Services
3.3.1 Clinical-Stage Manufacturing: Submarket Forecast 2015-2025
3.3.2 Commercial-Stage Manufacturing: Submarket Forecast 2015-2025
3.4 Leading Contract Manufacturing Organisations (CMOs)
3.4.1 Catalent Pharma Solutions: The Market Leader
3.4.1.1 Expanding in Clinical and Biopharma Manufacturing
3.4.2 Lonza: An Expert in Biopharma Manufacturing
3.4.2.1 Lonza and Advanced Biopharma Manufacturing
3.4.3 Evonik Degussa: A Small Molecule Specialist
3.4.3.1 Growth in HPAPI Manufacturing
3.4.4 Royal DSM
3.4.4.1 Adding Biopharma Capacity
3.4.5 Teva API: The World’s Largest API Manufacturer
3.4.5.1 Will Teva Expand in Emerging Markets?
3.4.6 Patheon
3.4.6.1 Patheon Is Adding New Formulation Development Services
3.4.7 Boehringer BioXcellence: Boehringer’s Biopharma Manufacturing Division
3.4.7.1 Adding New Services for Growth
3.4.8 Famar
3.4.9 Fareva
3.4.10 Vetter Pharma: Aseptic Filling for Biologics and Small Molecules
3.4.10.1 Vetter Offers its Clients New Services
4. The Contract API Manufacturing Submarket: Outlook 2015-2025
4.1 The Contract API Manufacturing Submarket 2013
4.1.1 The API Manufacturing Submarket by Sector 2013
4.2 The Contract API Manufacturing Submarket Outlook 2014-2025
4.2.1 The Contract API Manufacturing Submarket Forecast 2015-2025
4.2.2 What Will Drive Submarket Growth to 2025?
4.2.2.1 The Potential for Microreactors in Commercial Manufacturing to 2025
4.2.3 How Will New EU Regulations Impact the API Manufacturing Submarket?
4.2.4 Contract API Manufacturing Submarket Restraints 2015-2025
4.2.4.1 Backwards Integration for Generics Manufacturers
4.3 The Contract Generic API Manufacturing Submarket 2015-2025
4.3.1 The Contract Generic API Manufacturing Submarket Forecast 2015-2025
4.3.2 The Contract Generic API Manufacturing Submarket Drivers and Restraints to 2025
4.3.2.1 The US Generic Drug User Fee Act and API Manufacturing
4.4 The Contract HPAPI Manufacturing Submarket 2015-2025
4.4.1 Challenges and Opportunities in High Containment Manufacturing
4.4.2 Many Companies Are Investing in HPAPI Manufacturing Facilities
4.4.3 The Contract HPAPI Manufacturing Submarket Forecast 2015-2025
4.4.4 Submarket Drivers and Restraints 2015-2025
5. The Contract FDF Manufacturing Submarket Outlook 2015-2025
5.1 The Contract FDF Manufacturing Submarket 2013
5.1.1 Solid Dosage Manufacturing Leads the Market
5.1.2 CMOs Report High Demand for Softgel Formulations
5.2 The Contract FDF Manufacturing Submarket Forecast 2015-2025
5.2.1 Complex Molecule Manufacturing Will Drive Growth to 2025
5.2.2 What Will Restrain Growth in FDF Outsourcing?
5.3 The Contract Solid Dosage Manufacturing Submarket 2015-2025
5.3.1 How Will Revenues for Solid Dosage Manufacturing Grow 2015-2025?
5.3.2 Submarket Drivers and Restraints 2015-2025
5.3.2.1 Will Product Reformulation Drive Growth to 2025?
5.4 The Contract Injectable Dosage Manufacturing Submarket 2015-2025
5.4.1 The Contract Injectable Dosage Manufacturing Submarket Forecast 2015-2025
5.4.1.1 Drug Shortages Offer an Opportunity for CMOs in the Short Term
5.4.2 Demand for Biopharma Manufacturing Will Drive Growth 2015-2025
5.4.2.1 Interest in Antibody Drug Conjugate Development Is Growing
5.4.2.2 Challenges in Manufacturing Antibody Drug Conjugates
5.4.3 Lyophilisation and Aseptic Filling Demand Will Rise
5.4.3.1 Will Spray Drying Replace Lyophilisation in FDF Manufacturing?
6. Pharma Contract Manufacturing: Leading Developed National Markets 2015-2025
6.1 Leading National Markets for Pharma Contract Manufacturing 2013
6.1.1 Challenges in Assessing the Market: Supply vs. Demand
6.1.2 Leading National Pharma Contract Manufacturing Markets: Revenue Forecasts 2015-2025
6.2 The US Is the Leading National Market in Terms of Demand
6.2.1 Pharma Manufacturing in the US: Regulatory Oversight 2013
6.2.1.1 Controlling Foreign Manufacturing Sites
6.2.1.2 What Impact Will the GDUFA 2012 Have on Foreign Manufacturing?
6.2.1.3 Outsourcing and US Manufacturing Regulations
6.2.2 Increased Demand for Domestic API Manufacturing?
6.2.3 The US Contract Manufacturing Submarket Forecast 2015-2025
6.3 Outlook for Pharma Contract Manufacturing in the EU
6.3.1 The EU is the Leading Destination for Pharma Contract Manufacturing
6.3.2 Regulatory Aspects to Pharma Manufacturing in the EU
6.3.2.1 The European Commission Amends Annex 16
6.3.2.2 The Falsified Medicine Directive: Controlling API Imports
6.3.3 Biopharma Manufacturing Demand Will Rise to 2025
6.3.4 The EU Contract Manufacturing Submarket Forecast 2015-2025
6.3.5 Germany: The Leading EU Destination for API and FDF Manufacturing
6.3.5.1 Demand for Contract Manufacturing in Germany: Revenue Forecast 2015-2025
6.3.6 CMOs Account for a Third of Manufacturing Sites in France
6.3.6.1 French Pharma Contract Manufacturing Submarket Forecast 2015-2025
6.3.7 Italy: Strong API Manufacturing Traditions
6.3.7.1 Revenue Forecast for the Italian Pharma Contract Manufacturing Submarket 2015-2025
6.3.8 Spain: How Will Demand for Manufacturing Services Grow to 2025?
6.3.9 The UK: Pharma Contract Manufacturing Submarket Forecast 2015-2025
6.4 Pharma Contract Manufacturing in Japan 2015-2025
6.4.1 Pharma Manufacturing Regulations in Japan
6.4.1.1 The Pharmaceutical Affairs Law
6.4.2 Greater API Outsourcing to Drive Japanese Submarket Growth to 2025
7. Pharma Contract Manufacturing: Leading Emerging National Markets 2015-2025
7.1 Pharma Contract Manufacturing in Developing Countries
7.1.1 Outsourcing to Emerging National Markets from Developed Markets
7.1.1.1 Demand for Services in India and China
7.1.2 Domestic Demand for Pharma Contract Manufacturing Services
7.1.3 Pharma Contract Manufacturing: Leading Emerging National Market Forecasts 2015-2025
7.2 Chinese Demand for Pharma Contract Manufacturing Services 2015-2025
7.2.1 Improved Manufacturing Regulations in China
7.2.1.1 New Regulations for Excipients and Guidance for API Manufacturing 2012-2013
7.2.1.2 What Are the Consequences to Stricter Manufacturing Regulations in China?
7.2.2 Chinese CMOs Are Investing in Biopharma Manufacturing
7.2.3 China Pharma Contract Manufacturing Submarket Forecast 2015-2025
7.3 India: CMOs with Growing Formulation Experience
7.3.1 Regulatory Outlook for Indian Pharma Manufacturing
7.3.1.1 Ensuring Compliance with New Rules in the EU
7.3.2 Domestic Manufacturing Dominates the Indian Pharma Market
7.3.3 Demand for Contract Manufacturing in India: Submarket Forecast 2015-2025
7.4 Brazil: Contract Manufacturing Outlook 2013-2025
7.4.1 Pharma Manufacturing Regulations in Brazil
7.4.1.1 New Guidelines and Regulations Proposed 2012-2013
7.4.2 Brazil Imports Most of its APIs
7.4.3 Brazil: Pharma Contract Manufacturing Submarket Forecast 2015-2025
7.5 The Russian Pharma Contract Manufacturing Submarket 2015-2025
7.5.1 Pharma Manufacturing Regulations in Russia
7.5.1.1 Compliance with GMP in Russia
7.5.2 How Will Demand for Contract Manufacturing Grow in Russia 2015-2025?
7.6 South Korea
7.6.1 South Korea: Strict GMP Regulations
7.6.2 South Korea: Pharma Contract Manufacturing Submarket Forecast 2015-2025
8. Pharma Contract Manufacturing Industry Trends: CMO Perspective 2015-2025
8.1 Pharma Contract Manufacturing Market: Strengths and Weaknesses for CMOs 2013-2014
8.2 Pharma Contract Manufacturing Market: Opportunities and Threats for CMOs 2015-2025
8.3 Pharma Contract Manufacturing Market: STEP Analysis 2015-2025
8.3.1 Social Factors
8.3.2 New Technologies Will Drive Market Growth to 2025
8.3.2.1 Single-Use Technologies in Biopharma Manufacturing
8.3.2.2 Green Technology in Contract Manufacturing
8.3.2.3 Drug Delivery Trends and CMOs
8.3.2.4 Biologics Are Causing Increased Demand for Lyophilisation
8.3.2.5 Improving Solubility and Stability for Small Molecules
8.3.2.6 Spray Drying as an Alternative to Lyophilisation
8.3.2.7 Hot-Melt Extrusion
8.3.3 Economic Pressures
8.3.3.1 Developed-Market CMOs Face Competition from Emerging Markets
8.3.4 Political Issues
8.3.4.1 How Will Regulatory Developments Affect CMOs?
8.4 Trends in Drug Development Affecting CMOs to 2025
8.4.1 Orphan Drug Development: Smaller Manufacturing Capacities
8.4.2 Complex Biologics: Interest in ADCs is Rising
8.4.3 How Will Biosimilar Market Growth Affect CMOs?
8.4.4 The Future of Small Molecule Outsourcing
8.5 How Will CMOs Expand in the Coming 10 Years?
8.5.1 CMO Consolidation Will Increase
8.5.2 There Will be More Manufacturing Facilities Available for Acquisition
8.6 Developments in the Manufacturing Process 2015-2025
8.6.1 Quality by Design (QbD)
8.6.2 A Move Towards Continuous Manufacturing?
9. Pharma Contract Manufacturing Industry Trends: Client Perspective 2015-2025
9.1 Pharma Contract Manufacturing: Client Perspective Industry Strengths and Weaknesses 2013-2014
9.2 Pharma Contract Manufacturing: Client Perspective Industry Opportunities and Threats 2015-2025
9.3 Important Aspects of the Outsourcing Decision
9.3.1 What Factors Will Influence CMO Selection?
9.3.2 CMO-Pharma Partnering Models
9.3.3 Strategic Partnering
9.3.4 Selecting a Local CMO vs. Offshoring
9.3.5 CMOs in Emerging Markets
9.3.6 Communication
9.3.7 Ensuring Protection in Intellectual Property and Tech Transfer
9.3.8 Regulatory Compliance is a Key Deciding Factor for Pharma Clients
9.3.8.1 Regulatory Bodies and Outsourcing
9.3.8.2 Quality Agreement
9.3.8.3 Global Harmonisation Will Improve Compliance
9.4 Trends in Outsourcing Partnerships 2015-2025
9.4.1 Big Pharma and Outsourced Manufacturing
9.4.2 Small and Virtual Pharma Companies
9.4.3 How Will Biotech Funding Affect the Pharma Contract Manufacturing Industry to 2025?
10. Research Interviews from Our Industry Survey
10.1 Dr Cynthia Wooge, Global Strategic Marketing Manager, SAFC
10.1.1 SAFC
10.1.2 Are ADCs Limited to Oncology?
10.1.3 The Challenges of ADCs Manufacturing
10.1.4 What Solution Does SAFC Offer for ADCs Manufacturing?
10.1.5 Advancement in Conjugation Technology
10.2 Mr. Peter Soelkner, Managing Director of Vetter Pharma International GmbH
10.2.1 Vetter
10.2.2 Singapore, a Global Biomedical Sciences Hub
10.2.3 Market Outlook for APAC Region
10.2.4 Challenges to Be Addressed in the APAC Region
11. Conclusions of the Study
11.1 The World Pharma Contract Manufacturing Market
11.2 Outlook for the Market to 2025
11.2.1 Rising Demand for High Value Services 2015-2025
11.2.2 Demand Will be Highest Among Developed Market Clients
11.3 Which New Technologies Will Stimulate Demand to 2025?
【レポート販売概要】
■ タイトル：医薬品製造受託（CMO）サービスの世界市場■ 英文：Pharmaceutical Contract Manufacturing: World Industry and Market Outlook 2015-2025
■ 発行日：2015年2月
■ 調査会社：visiongain
■ 商品コード：VGAIN502207
■ 調査対象地域：グローバル
- 水性エポキシ樹脂の世界市場2017-2021：塗料用途、接着剤用途、複合材料用途About Waterborne Epoxy Resins Waterborne epoxy resins are thermosetting resins that are used in various end-user industries such as automotive, textile, construction, furniture, packaging, and other end-user industries. They demonstrate high gloss, excellent chemical and corrosion resistance, good adhesion, high mechanical stability, high flexibility and compatibility, optimized performance, and g …
- 垂直離着陸（VTOL）無人機（UAV）の世界市場2016-2020About VTOL UAV VTOL UAVs are are capable of performing vertical take-off and landing and do not require a runway. VTOL UAVs can be further classified into multi-rotors (quadcopters, hexacopters, and octocopters), helicopter-configured UAVs, and tiltrotor VTOL UAVs. These UAVs are mostly used for applications where stability and hover capability is crucial. Technavio’s analysts forecast the global …
- デオドラント・制汗剤原料の世界市場2019-2023About this market Increasing demand for male grooming products to drive market growth. The male grooming product sector is a lucrative market, and deodorants and antiperspirants are among the popular products in this segment. The popularity of male grooming products has increased as men are increasingly using them as a part of their daily grooming routine. The male grooming product sector in devel …
- セルベースアッセイの世界市場：セルベースアッセイ装置/消耗品/サービスCellular testing for pharmaceuticals – how to discover that technology’s commercial potential What’s the future of technologies for screening cells? Now discover those technological and commercial predictions from 2015. Stay ahead there for data, benefiting your influence. For those medical tests, you explore sales results, R&D, opportunities and revenue forecasts. That new report by visiongain sh …
- 世界の通信キャリア動向：Light operators（MVNO、ホールセール、オープン・アクセス・ネットワーク等）n/a
- 世界の菓子類市場動向（2014年4月）：ニュース・イベントSynopsis Using this report, marketers will effectively gain an insight into the latest happenings in the global confectionery market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global confectionery market on a monthly basis. Scope The report provides a review of the latest news and key events in the g …
- 飼料用酸味料の世界市場予測（～2023年）“Ban on antibiotics in feed are expected to drive the overall growth of the feed acidulants market.” The global feed acidulants market is projected to grow from USD 2.7 billion in 2018 to USD 3.5 billion by 2023, at a CAGR of 5.1% during the forecast period. The feed acidulants market is driven by various factors such as growth in animal husbandry, increase in demand for feed and feed additives, r …
- 介入的脊椎装置の世界市場2017-2021：椎体形成術、椎骨形成術、ラジオ波焼灼術About Interventional Spine Devices Interventional spine procedures are used to treat painful spinal conditions. Interventional treatment options are often more efficient and effective than traditional therapy for spinal (back and neck) pain. The new techniques are excellent minimally invasive alternatives to conventional surgery. Lumbar disc disease, sacroiliac joint, and degenerative lumbar facet …
- 人工リフトポンプの世界市場2016-2020About the Artificial Lift Pumps Market As a direct impact of the ambiguity in the oil market, the global artificial lift pumps market has been experiencing sluggishness in the recent past as it has become enmeshed with the turmoil in the global oil industry. Declining prices, deferred investments, investor skepticism, and an unpredictable future in the commodity's outlook are inhibiting the growth …
- PLCスプリッタの世界市場予測及び分析This is the ElectroniCast analysis and forecast of global market consumption of planar lightwave circuit (PLC) splitters used in optical communication applications. For the purposes of this study, ElectroniCast specifically addresses the PLC splitter, using waveguide circuits and aligned fiber optic pigtails, integrated inside a package. The 2014-2019 quantitative market forecast data presented in …
- 3Dスキャナーの世界市場：レーザー式3Dスキャナー、構造化光式3Dスキャナー3D scanners capture and measure geometry of physical object or environment by using lasers or structured light. Data captured by these 3D scanners are often called as point clouds, which are used by software to create 3D representation of the scanned object or physical environment for in-depth analysis, inspection, and modification. 3D scanners find wide application across several industries to en …
- 医療用ロボットが転換するヘルスケア市場：価格、費用対効果分析、医療費償還、選定基準、購買サイクルMedical robots are increasingly being adopted by hospitals and patients across the globe, particularly in the U.S. Demographic change, shortage of healthcare professionals, need to improve quality of life for the disabled and elderly, and need to improve surgical procedures coupled with the focus to develop technologically advanced robots are some of the factors expected to stimulate growth the ad …
- アップルTV対グーグルTV（Apple TV vs. Google TV）This research evaluates Google vs. Apple TV as well as analyzes other companies in the space. The research reviews solutions, technologies, and applications. The report also provides a comparative analysis of offerings including Business, Sports, and Music.
- Delphi Energy Corp.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Delphi Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Delphi Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- 世界の軍用回転翼航空機の市場動向2013-2023：競合環境及び戦略的インサイトThe report provides a detailed analysis of the competitive landscape of the Military Rotorcraft market. It provides an overview of key Military Rotorcraft companies catering to the Military Rotorcraft sector, together with insights such as key alliances, strategic initiatives and a brief financial analysis. The global rotorcraft industry is highly concentrated with the majority of the market captu …
